Engineering and Manufacturing Enablement for Affordable Respiratory Care Solutions

We transferred and localized a Bubble CPAP device into a cost-optimized, ISO 13485-compliant manufacturing ecosystem. This strengthened supply continuity and ensured clinical reliability.

March 8, 2026

Respiratory Care | USA

We transferred and localized a Bubble CPAP device into a cost-optimized, ISO 13485-compliant manufacturing ecosystem. This strengthened supply continuity and ensured clinical reliability.

Key Impact Metrics

  • 20–25% reduction in total device cost through localization and redesign
  • An India-centric supply chain established to reduce import dependency and shorten lead times.
  • DFM-driven tooling upgrades and enhanced component reliability
  • Predictable scale-up achieved through dedicated plastics manufacturing infrastructure.

Discuss Your Manufacturing Program

Client Overview

A neonatal care innovator engaged us to transfer its Bubble CPAP respiratory device into a scalable, compliant, and cost-efficient manufacturing ecosystem. The scope covers tooling and mold preparation, localized sourcing, regulatory alignment, and packaging readiness to improve reliability, reduce cost pressures, and stabilize supply continuity.

 

Business Challenge

Strategic Challenge

The client aimed to stabilize and shorten its supply chain while preparing the Bubble CPAP system for mass production. Reliance on imported components resulted in long lead times, cost volatility, and supply uncertainty, limiting responsiveness to neonatal care demand.

Technical Challenge

The existing design required manufacturability refinement to enable repeatable plastics molding, assembly precision, and sustained product reliability. Tooling upgrades and process optimization ensured consistent output quality at scale.

Regulatory & Compliance Challenge

Localization of manufacturing required alignment with ISO 13485 quality systems, documentation integrity, and regional regulatory registrations. CDSCO registration support maintained traceability and compliance during the manufacturing transfer.

Manufacturing & Scale Challenge

The project required a facility capable of advanced medical-grade plastic molding and assembly in accordance with ISO 13485. Supply chain restructuring was critical to reduce import dependency and establish predictable production volumes.

India-Centric Supply Chain Stabilization

We established an India-centric, globally aligned supplier ecosystem to ensure reliable sourcing and shorter lead times. Localized material procurement and onboarding of vetted domestic suppliers reduced import dependency and strengthened traceability and quality oversight.

Design for Manufacturability (DFM) Optimization

A structured DFM review of the device enhanced tooling architecture, improved part manufacturability, and increased component reliability. Process repeatability was strengthened, defect risk minimized, and cost efficiency improved. 

Tooling & Plastics Manufacturing Enablement

Molds were prepared and validated to meet medical plastics requirements. Production was integrated into a dedicated ISO 13485-compliant plastics manufacturing facility supporting neonatal respiratory device programs. 

Regulatory & Compliance Support

CDSCO registration assistance and documentation alignment were delivered during the manufacturing transfer. Integration of the quality management system ensured traceability, audit readiness, and regulatory compliance. 

Scale-Ready Production Framework

Validated processes, coordinated supplier management, and optimized assembly workflows enabled predictable scale-up aligned with projected neonatal care demand. 

 

Results & Business Impact

Measurable Outcomes
  • 20-25% reduction in total device cost through localization and redesign 
  • Significant lead time reduction achieved through the India-based supply chain 
  • Enhanced tooling precision and increased product reliability 
Operational Impact

Localized sourcing and optimized manufacturing workflows improved supply continuity and production predictability. 

Regulatory Outcome

Alignment with ISO 13485 processes and CDSCO registration support was achieved during manufacturing transfer. 

Market Outcome

Readiness to meet neonatal respiratory care demand improved through a stable, scalable production framework. 

 

Enabling Scalable, Cost-Optimized Neonatal Care Manufacturing

As a design-led medical device CDMO, we integrate manufacturability engineering, regulatory alignment, and supply chain localization to deliver scalable, reliable solutions for complex medical innovations. 

Recent Case Studies

March 3, 2026

Case Study

March 2, 2026

Case Study

March 10, 2026

Case Study